Story thread · 3 reports / 3 sources
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
cnbc.com · 3h · first report
The coverage
- Lilly's Foundayo pill wins over a third of new patients, CEO says
qz.com · 3h
- Lilly CEO Dave Ricks says Foundayo winning new pill patients
finance.yahoo.com · 3h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.